SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-121600
Filing Date
2020-11-05
Accepted
2020-11-05 08:18:25
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2034385-1_10q.htm 10-Q 1034244
2 EXHIBIT 31.1 tm2034385d1_ex31-1.htm EX-31.1 8709
3 EXHIBIT 31.2 tm2034385d1_ex31-2.htm EX-31.2 8779
4 EXHIBIT 32.1 tm2034385d1_ex32-1.htm EX-32.1 4147
5 EXHIBIT 32.2 tm2034385d1_ex32-2.htm EX-32.2 4117
  Complete submission text file 0001104659-20-121600.txt   6645287

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT repl-20200930.xml EX-101.INS 1639436
7 XBRL TAXONOMY EXTENSION SCHEMA repl-20200930.xsd EX-101.SCH 57075
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE repl-20200930_cal.xml EX-101.CAL 64670
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE repl-20200930_def.xml EX-101.DEF 154902
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20200930_lab.xml EX-101.LAB 509281
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20200930_pre.xml EX-101.PRE 358301
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 201288822
SIC: 2836 Biological Products, (No Diagnostic Substances)